TABLE 1.
Expt | Mouse strain | na | No. of splenocytes/spleen
|
Splenic CTL activity
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Day 0 p.i.
|
Days 7–8 p.i.
|
Days 10–11 p.i.
|
Days 13–15 p.i.
|
Day 0 p.i.
|
Days 7–8 p.i.
|
Days 10–11 p.i.
|
Days 13–15 p.i.
|
|||||||||||
CD3+ (107) | CD3+ CD8+ (107) | CD3+ (107) | CD3+ CD8+ (107) | CD3+ (107) | CD3+ CD8+ (107) | CD3+ (107) | CD3+ CD8+ (107) | % Specific lysisc | Total LUd | % Specific lysis | Total LU | % Specific lysis | Total LU | % Specific lysis | Total LU | |||
1 | 129 | 2 | 5.8 | 0.6 | 9.5 | 0.6 | 14.3 | 2.8 | 8.3 | 1.0 | 7 | <1 | 38 | 108 | 64 | 551 | 30 | 35 |
IFN-γ R−/− | 2 | 6.2 | 0.5 | 10.4 | 1.2 | 11.3 | 2.4 | 15.3 | 2.0 | 6 | <1 | 60 | 256 | 69 | 339 | 58 | 341 | |
2 | 129 | 2 | 3.9 | 0.6 | 4.7 | 0.8 | 2.3 | 1.9 | 3.6 | 1.5 | −2 | <1 | 28 | 111 | 39 | 199 | 21 | 75 |
IFN-γ R−/− | 2 | 3.2 | 0.7 | 4.6 | 1.1 | 3.4 | 1.9 | 4.9 | 2.0 | −3 | <1 | 29 | 171 | 43 | 222 | 27 | 149 | |
3 | 129 | 4 | NDb | ND | 5.7 | 2.0 | ND | ND | 4.0 | 1.8 | ND | ND | 17 | 73 | ND | ND | 18 | 78 |
IFN-γ R−/− | 3 | ND | ND | 2.5 | 1.2 | ND | ND | 3.9 | 3.0 | ND | ND | 13 | 75 | ND | ND | 30 | 396 | |
4 | 129 | 2 | 2.9 | 0.6 | ND | ND | 3.5 | 2.4 | 2.5 | 1.6 | −1 | <1 | ND | ND | 37 | 173 | 24 | 48 |
IFN-γ R−/− | 2 | 2.1 | 1.5 | ND | ND | 2.9 | 1.4 | 4.7 | 3.6 | −2 | <1 | ND | ND | 39 | 196 | 34 | 233 | |
5 | 129 | 2 | ND | ND | 1.7 | 1.3 | ND | ND | ND | ND | ND | ND | 50 | 175 | ND | ND | ND | ND |
IFN-γ R−/− | 2 | ND | ND | 1.7 | 0.9 | 1.5 | 1.1 | 4.3 | 3.0 | ND | ND | 31 | 111 | 36 | 155 | 35 | 181 |
Number of mice per experiment. The results for the 129 mice are from pooled spleens. The results for the IFN-γ R−/− mice are averages of individual mice.
ND, not done.
At effector-to-target cell ratio of 100:1 (see Materials and Methods).
See Materials and Methods.